1. 1 2. 1Q11 Earnings Release May, 11th, 2011 2 3. Highlights in the Period• In May 2011, Profarma celebrates its 50th Anniversary. The Company’s result-oriented culture,…

1. 1Q10 Earnings Release May, 13th, 2010. 2. 1Q10 Earnings ReleaseHighlights For The Period• Gross revenue reached R$ 766.0 million, showing a 15.8% growth when comparing…

1. 1 2. 3Q12 Earnings Release November, 8th, 2012 2 3. 3Q12 Results | Highlights in the Period• Entry into the special and high value-added medication market on July 23,…

1. INTERIM CONSOLIDATED FINANCIAL STATEMENTS (An Exploration Stage Company) JANUARY 31, 2010These unaudited financial statements for the period ended January 31, 2010 have…

1. 1 2. 4Q12 and 2012 Earnings Release March, 27, 2013 2 3. Highlights in the Period• The Companys consolidated net income rose by 53.6% year-over-year to R$ 40.6 million,…

1. FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, DC 20549 [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF…

1. BusinessDeveloping Implementing SpreadingProcessIdeaIdea Idea Period 2011.09.05101 Days2011.12.14Finance1,000,000 168%1,680,000Product/BlackAngel’sBlaq N GelsService…

1. 3Q09 Earnings Release November, 9th, 2009. 2. 3Q09 Earnings ReleaseHighlights For The Period• The Company’s net income increased 164.2% in relation to the 3Q08, reaching…

1. 1 Earnings Release 1T08 2. Highlights For The Period2 • Growth of 26.5% in consolidated Gross Revenue when compared to the same period of the previous year, reaching…

1. 1 2. 1Q11 Earnings Release May, 11th, 2011 2 3. Highlights in the Period• In May 2011, Profarma celebrates its 50th Anniversary. The Company’s result-oriented culture,…